Both in Pharmaceuticals
Milestone Pharmaceuticals vs Perspective Therapeutics
Over the past year MIST returned −58.0% and CATX returned −62.7%; their daily moves had a correlation of 0.24.
MIST −58.0% CATX −62.7%Growth of $1, one year, split-adjusted
| Metric | MIST | CATX |
|---|---|---|
| Price | $0.7725 | $0.8702 |
| Market cap | $96.2M | $99.3M |
| Today | +1.74% | −1.11% |
| 1 month | +1.1% | −63.1% |
| 6 months | −60.8% | −77.2% |
| Year to date | −61.8% | −68.4% |
| 1 year | −58.2% | −66.5% |
| Revenue growth (YoY) | — | −72.1% |
| Gross margin | 94.3% | 100.0% |
| Net margin | −5118.8% | −33069.1% |
| P/E (TTM) | — | — |
| Price / sales | 41.0× | 242.9× |
| Net cash | $111.4M | $235.3M |
| Dividend yield | — | — |
| Volatility (60d) | 74.2% | 117.1% |
| Short % of float | 17.9% | 17.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).